Safety and efficacy of transcatheter embolization in patients with massive hemoptysis due to intercostal pulmonary venous shunts

Fu, Zhe; Liang, Yan; Zhao, Wengjiang; Tian, Jie; Cai, Fei; Zhang, Xiaolin

doi:10.1007/s11547-019-01020-0

Cited by 5 publications

(6 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A proportional meta-analysis was performed for all studies that used a common mode of management of massive hemoptysis, that is, BAE, and provided relevant data [45][46][47][48][49][50][51][52][53][54]56,57,[59][60][61][62][63][64]66,[68][69][70][71][72]74].…”

Section: Meta-analysis Resultsmentioning

confidence: 99%

“…In this systematic review, 30 studies related to the management of massive hemoptysis were included, of which 26 used bronchial artery embolization as a management method [45][46][47][48][49][50][51][52][53][54]56,57,[59][60][61][62][63][64][66][67][68][69][70][71][72]74]. The 30 studies were observational retrospective cohort studies.…”

Section: Discussionmentioning

confidence: 99%

“…In these cases, surgical treatment of hemoptysis should be discussed to reduce the risk of rebleeding. Many times, during follow-up, the need for re-interventions can be seen [45][46][47][48][49][50][51][52][53][54]56,57,[59][60][61][62][63][64][66][67][68][69][70][71][72]74].…”

Section: Discussionmentioning

confidence: 99%

“…Such factors are diabetes, aspergilloma, and the existence of an arteriovenous shunt. In particular, with regard to aspergilloma, rebleeding can reach 100%, emphasizing the need for regular follow-up and discussion of surgical lobectomy if the patient is deemed cardiorespiratorily fit for such an operation [45][46][47][48][49][50][51][52][53][54]56,57,[59][60][61][62][63][64][66][67][68][69][70][71][72]74].…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Karlafti,

Tsavdaris,

Kotzakioulafi

et al. 2023

JPM

View full text Add to dashboard Cite

Introduction: Hemoptysis is one of the most common symptoms of respiratory system diseases. Common causes include bronchiectasis, tumors, tuberculosis, aspergilloma, and cystic fibrosis. The severity of hemoptysis varies from mild to moderate to massive hemoptysis and can easily lead to hemodynamic instability and death from suffocation or shock. Nevertheless, the most threatening hemoptysis that is presented to the emergency department and requires hospitalization is the massive one. In these cases, today, the most common way to manage hemoptysis is bronchial artery embolization (BAE). Methods: A systematic literature search was conducted in PubMed and Scopus from January 2017 (with the aim of selecting the newest possible reports in the literature) until May 2023 for studies reporting massive hemoptysis. All studies that included technical and clinical success rates of hemoptysis management, as well as rebleeding and mortality rates, were included. A proportional meta-analysis was conducted using a random-effects model. Results: Of the 30 studies included in this systematic review, 26 used bronchial artery embolization as a means of treating hemoptysis, with very high levels of both technical and clinical success (greater than 73.7% and 84.2%, respectively). However, in cases where it was not possible to use bronchial artery embolization, alternative methods were used, such as dual-vessel intervention (80% technical success rate and 66.7% clinical success rate), customized endobronchial silicone blockers (92.3% technical success rate and 92.3% clinical success rate), antifibrinolytic agents (50% clinical success rate), and percutaneous transthoracic embolization (93.1% technical success rate and 88.9% clinical success rate), which all had high success rates apart from antifibrinolytic agents. Of the 2467 patients included in these studies, 341 experienced rebleeding during the follow-up period, while 354 other complications occurred, including chest discomfort, fever, dysphagia, and paresis. A total of 89 patients died after an episode of massive hemoptysis or during the follow-up period. The results of the meta-analysis showed a pooled technical success of bronchial artery embolization equal to 97.22% and a pooled clinical success equal to 92.46%. The pooled recurrence was calculated to be 21.46%, while the mortality was 3.5%. These results confirm the ability of bronchial artery embolization in the treatment of massive hemoptysis but also emphasize the high rate of recurrence following the intervention, as well as the risk of death. Conclusion: In conclusion, massive hemoptysis can be treated with great clinical and technical success using bronchial artery embolization, reducing mortality. Mortality has now been reduced to a small percentage of cases.

show abstract

Section: Meta-analysis Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Karlafti,

Tsavdaris,

Kotzakioulafi

et al. 2023

JPM

View full text Add to dashboard Cite

show abstract

“…Treatment strategies for SPAS are not well established, and there is no consensus or guidelines regarding the optimal management approach. Non-surgical options include embolization of the systemic arteries using TAE techniques [ 7 , 12 ]. However, there is a risk of vessel recanalization and the development of collateral vessels [ 6 ].…”

Section: Discussionmentioning

confidence: 99%

Systemic-to-pulmonary artery shunt treated with transcatheter arterial embolization and subsequent lung segmentectomy

Notsuda,

Tomiyama,

Onodera

et al. 2023

Egypt Heart J

View full text Add to dashboard Cite

Background Systemic-to-pulmonary artery shunt (SPAS) is a rare condition that can occur as a result of congenital heart disease or chronic pulmonary inflammation, occasionally leading to life-threatening hemoptysis. Computed tomography (CT) imaging is crucial in the diagnosis of SPAS, and the optimal management approach for SPAS remains uncertain. This case report presents a novel approach to the treatment of SPAS, consisting of transcatheter arterial embolization of the systemic artery followed by lung segmentectomy. Case presentation A 42-year-old man with abnormal chest findings was referred to us and a diagnosis of SPAS was established based on the CT findings showing a blood flow regurgitation from the dilated left 4th intercostal artery to the Lt. A6. The patient was asymptomatic but we decided to treat him to prevent a risk of future hemoptysis. Transcatheter arterial embolization (TAE) of systemic arteries followed by S6 segmentectomy was successfully performed with minimal blood loss and complete removal of the dilated intra-pulmonary blood vessels. Histological analysis confirmed the diagnosis of SPAS. Conclusion We reported a case of SPAS, who was successfully treated with the combination of TAE and subsequent segmentectomy. The blood loss during surgery was minimal and this strategy appeared to minimize future recanalization and hemoptysis. Further studies and long-term follow-up of SPAS patients are required to establish standardized management guidelines for this rare condition.

show abstract

Re: Safety and efficacy of transcatheter embolization in patients with massive haemoptysis due to intercostal pulmonary venous shunts

Alsafi

Jackson

2020

Radiol med

View full text Add to dashboard Cite

Safety and efficacy of transcatheter embolization in patients with massive hemoptysis due to intercostal pulmonary venous shunts

Cited by 5 publications

References 17 publications

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies

Systemic-to-pulmonary artery shunt treated with transcatheter arterial embolization and subsequent lung segmentectomy

Re: Safety and efficacy of transcatheter embolization in patients with massive haemoptysis due to intercostal pulmonary venous shunts

Contact Info

Product

Resources

About